Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: first report of Intergroup Trial C9741/Cancer and Leukemia Group B Trial 9741.
- Citation:
- J Clin Oncol vol 21 (8) 1431-9
- Year:
- 2003
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- Parents:
- None
- Children:
- None
- Pharmas:
- Grants:
- Corr. Author:
- Authors:
- Marc L Citron Donald A Berry Constance Cirrincione Clifford Hudis Eric P Winer William J Gradishar Nancy E Davidson Silvana Martino Robert Livingston James N Ingle Edith A Perez John Carpenter David Hurd James F Holland Barbara L Smith Carolyn I Sartor Eleanor H Leung Jeffrey Abrams Richard L Schilsky Hyman B Muss Larry Norton
- Networks:
- Study
- CALGB-9741
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 3
- Keywords:
- Adult, Aged, Antineoplastic Combined Chemotherapy Protocols, Breast Neoplasms, Chemotherapy, Adjuvant, Cyclophosphamide, Doxorubicin, Drug Administration Schedule, Female, Filgrastim, Granulocyte Colony-Stimulating Factor, Humans, Middle Aged, Multivariate Analysis, Paclitaxel, Proportional Hazards Models, Recombinant Proteins, Survival Analysis, Treatment Outcome